Cargando…

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

BACKGROUND: ASPM (Abnormal Spindle-like Microcephaly associated) over-expression was recently implicated in the development of malignant gliomas. RESULTS: To better characterize the involvement of ASPM in gliomas, we investigated the mRNA expression in 175 samples, including 8 WHO Grade II, 75 WHO G...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikeye, Sandra-Nadia Ngwabyt, Colin, Carole, Marie, Yannick, Vampouille, Raphaël, Ravassard, Philippe, Rousseau, Audrey, Boisselier, Blandine, Idbaih, Ahmed, Calvo, Charles Félix, Leuraud, Pascal, Lassalle, Myriam, El Hallani, Soufiane, Delattre, Jean-Yves, Sanson, Marc
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817685/
https://www.ncbi.nlm.nih.gov/pubmed/20142996
http://dx.doi.org/10.1186/1475-2867-10-1
_version_ 1782177225715482624
author Bikeye, Sandra-Nadia Ngwabyt
Colin, Carole
Marie, Yannick
Vampouille, Raphaël
Ravassard, Philippe
Rousseau, Audrey
Boisselier, Blandine
Idbaih, Ahmed
Calvo, Charles Félix
Leuraud, Pascal
Lassalle, Myriam
El Hallani, Soufiane
Delattre, Jean-Yves
Sanson, Marc
author_facet Bikeye, Sandra-Nadia Ngwabyt
Colin, Carole
Marie, Yannick
Vampouille, Raphaël
Ravassard, Philippe
Rousseau, Audrey
Boisselier, Blandine
Idbaih, Ahmed
Calvo, Charles Félix
Leuraud, Pascal
Lassalle, Myriam
El Hallani, Soufiane
Delattre, Jean-Yves
Sanson, Marc
author_sort Bikeye, Sandra-Nadia Ngwabyt
collection PubMed
description BACKGROUND: ASPM (Abnormal Spindle-like Microcephaly associated) over-expression was recently implicated in the development of malignant gliomas. RESULTS: To better characterize the involvement of ASPM in gliomas, we investigated the mRNA expression in 175 samples, including 8 WHO Grade II, 75 WHO Grade III and 92 WHO Grade IV tumors. Aspm expression was strongly correlated with tumor grade and increased at recurrence when compared to the initial lesion, whatever the initial grade of the primary tumor. ASPM expression also increased over serial passages in gliomaspheres in vitro and in mouse xenografts in vivo. Lentivirus-mediated shRNA silencing of ASPM resulted in dramatic proliferation arrest and cell death in two different gliomasphere models. CONCLUSION: These data suggest that ASPM is involved in the malignant progression of gliomas, possibly through expansion of a cancer stem cell compartment, and is an attractive therapeutic target in glioblastoma multiforme.
format Text
id pubmed-2817685
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28176852010-02-09 ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target Bikeye, Sandra-Nadia Ngwabyt Colin, Carole Marie, Yannick Vampouille, Raphaël Ravassard, Philippe Rousseau, Audrey Boisselier, Blandine Idbaih, Ahmed Calvo, Charles Félix Leuraud, Pascal Lassalle, Myriam El Hallani, Soufiane Delattre, Jean-Yves Sanson, Marc Cancer Cell Int Primary research BACKGROUND: ASPM (Abnormal Spindle-like Microcephaly associated) over-expression was recently implicated in the development of malignant gliomas. RESULTS: To better characterize the involvement of ASPM in gliomas, we investigated the mRNA expression in 175 samples, including 8 WHO Grade II, 75 WHO Grade III and 92 WHO Grade IV tumors. Aspm expression was strongly correlated with tumor grade and increased at recurrence when compared to the initial lesion, whatever the initial grade of the primary tumor. ASPM expression also increased over serial passages in gliomaspheres in vitro and in mouse xenografts in vivo. Lentivirus-mediated shRNA silencing of ASPM resulted in dramatic proliferation arrest and cell death in two different gliomasphere models. CONCLUSION: These data suggest that ASPM is involved in the malignant progression of gliomas, possibly through expansion of a cancer stem cell compartment, and is an attractive therapeutic target in glioblastoma multiforme. BioMed Central 2010-01-11 /pmc/articles/PMC2817685/ /pubmed/20142996 http://dx.doi.org/10.1186/1475-2867-10-1 Text en Copyright ©2010 Bikeye et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Primary research
Bikeye, Sandra-Nadia Ngwabyt
Colin, Carole
Marie, Yannick
Vampouille, Raphaël
Ravassard, Philippe
Rousseau, Audrey
Boisselier, Blandine
Idbaih, Ahmed
Calvo, Charles Félix
Leuraud, Pascal
Lassalle, Myriam
El Hallani, Soufiane
Delattre, Jean-Yves
Sanson, Marc
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title_full ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title_fullStr ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title_full_unstemmed ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title_short ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
title_sort aspm-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
topic Primary research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817685/
https://www.ncbi.nlm.nih.gov/pubmed/20142996
http://dx.doi.org/10.1186/1475-2867-10-1
work_keys_str_mv AT bikeyesandranadiangwabyt aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT colincarole aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT marieyannick aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT vampouilleraphael aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT ravassardphilippe aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT rousseauaudrey aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT boisselierblandine aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT idbaihahmed aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT calvocharlesfelix aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT leuraudpascal aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT lassallemyriam aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT elhallanisoufiane aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT delattrejeanyves aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget
AT sansonmarc aspmassociatedstemcellproliferationisinvolvedinmalignantprogressionofgliomasandconstitutesanattractivetherapeutictarget